// App-Quantinova.ai

3614 : Genotype-driven study of weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy of locally advanced rectal cancer.

Researchers

Presenter

  • Zhen Zhang

Principal Investigators

  • Ji Zhu

  • Yunzhu Shen

  • Juefeng Wan

  • Guichao Li

  • Ye Xu

  • Xinxiang Li

  • Sanjun Cai

Medical Centers

  • Fudan University Shanghai Cancer Center, Shanghai, China

  • Nanjing Medical University, Nanjing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • UDP glucuronosyltransferase family 1 member A1

Drug/Treatment

  • Capecitabine

  • Irinotecan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01474187

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved